Figure 3:
Comparison of interferon- (A) and TNF- (B) production in PBMC isolated from subjects receiving BIM product and placebo (n=5) upon TCR activation.
Figure 4:
Comparison of IL-4 (A), IL-5 (B) and IL-13 (C) production in PBMC isolated from subjects receiving BIM product and placebo (n=5) upon TCR activation.
|